
Why Diabetes Treatment Navigator?
Organ Protection First
Decouples glycemic targets from cardiorenal risk reduction, automating guideline-directed medical therapy (GDMT) with SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs (Finerenone) independent of baseline HbA1c.
Diagnostic Rigor & Verification
Implements ADA Section 2 concordant and discordant multi-test criteria to confirm diabetes diagnoses, prevent misclassifications, and identify prediabetes or pregnancy-specific thresholds instantly.
EHR-Ready Monospace Export
Synthesizes complex biometrics, trajectory trends, deprescribing steps, and individualized A1c targets into a clean, pre-formatted clinical note ready for one-click copy into Epic, Cerner, or ambulatory EHR systems.
Clinical Workflow: 4-Stage Architecture
Stage 1: Encounter Mode & Biometric Baseline
- Select between Mode 1 (New Diagnostic Verification) and Mode 2 (Established T2D Follow-Up & Treatment Plan).
- Automated body mass index (BMI) calculation and unit toggles (metric/imperial).
- Pre-loaded clinical cases for rapid scenario testing (ASCVD, CKD Stage 3a, HFpEF, Frail Elderly, Catabolic Hyperglycemia).
Stage 2: Longitudinal Labs & Trajectory Analysis
- Quantifies recent HbA1c vs. prior historical draw with dynamic directional delta (improving vs. escalating).
- Calculates glycemic gap against individualized goal and identifies immediate combination therapy thresholds (gap ≥ 1.5%).
- Automated KDIGO staging utilizing both eGFR (G1–G5) and Urine Albumin-to-Creatinine Ratio (UACR A1–A3) with serum potassium verification.
Stage 3: Comorbidity Stratification & Safety Alerts
- Flags compelling cardiorenal conditions: established ASCVD, Heart Failure (HFrEF/HFpEF), Chronic Kidney Disease, MASH/MASLD, and obesity.
- Evaluates severe hypoglycemia history to trigger aggressive secretagogue deprescribing and basal insulin dose de-escalation protocols.
- Pregnancy safety gate: instantly restricts teratogenic oral agents/statins/ACEi/ARBs and displays strict maternal-fetal glycemic targets.
Stage 4: Decision Support & Regimen Optimization
- Actionable Recommendations: First-line organ protection imperatives, stepwise intensification algorithms, and renal dose adjustment flags.
- Drug Class Comparator: Evidence grades, glycemic efficacy, weight impact, hypoglycemia risk, and renal thresholds across 10 drug classes.
- Basal Titration Worksheet: Bedside weight-based initiation (0.1–0.2 units/kg/day or 10 units) and outpatient titration protocols.
- Assessment & Plan Monospace Note: Monospaced summary synthesizing diagnostic verification, individualized targets, and plan details.
How to Use the Diabetes Treatment Navigator in Practice
- Select Encounter Context: Choose Mode 1 for diagnostic confirmation of discordant labs or Mode 2 for routine chronic disease follow-up and regimen adjustment.
- Enter Biometrics and Longitudinal Labs: Input current weight, age, recent/prior HbA1c, FPG, eGFR, UACR, and potassium levels to populate automated staging badges.
- Tag Comorbidities & Active Regimen: Check active patient conditions (ASCVD, HF, CKD, MASH) and select current anti-hyperglycemic agents to screen for safety conflicts or duplicate incretins.
- Review Tailored Interventions: Navigate the prioritized guidance tabs to inspect GDMT imperatives, basal titration calculations, or drug class renal thresholds.
- Export to EHR: Open the “Assessment & Plan Export” tab and click “Copy to Clipboard” to paste the complete clinical rationale directly into the encounter note.
